Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common stock, $0.001 par value per share
-
Shares outstanding
-
12,986,368
-
Total 13F shares
-
12,906,558
-
Share change
-
-265,584
-
Total reported value
-
$619,270,103
-
Put/Call ratio
-
0%
-
Price per share
-
$47.98
-
Number of holders
-
158
-
Value change
-
-$12,622,967
-
Number of buys
-
68
-
Number of sells
-
87
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) as of Q2 2020
As of 30 Jun 2020,
EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) was held by
158 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,906,558 shares.
The largest 10 holders included
BlackRock Inc., JANUS HENDERSON GROUP PLC, Park West Asset Management LLC, STATE STREET CORP, VANGUARD GROUP INC, Invesco Ltd., CREDIT SUISSE AG/, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, and ARMISTICE CAPITAL, LLC.
This page lists
158
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.